Home » Topics » BioWorld Science

BioWorld Science
RSS

AstraZeneca presents arginase-1 and arginase-2 inhibitors

Sep. 9, 2019

New PD-1/PD-L1 interaction inhibitors described by Gilead Sciences

Sep. 9, 2019

Enanta Pharmaceuticals discloses new farnesoid X receptor agonists

Sep. 9, 2019

Phase I results of inhaled 5-azacytidine for the treatment of advanced non-small cell lung cancer

Sep. 9, 2019

FDA approves Ofev for interstitial lung disease associated with scleroderma

Sep. 9, 2019

Bristol-Myers Squibb discovers STING agonists

Sep. 9, 2019

PRC2 inhibitors patented by Shanghai Institute of Materia Medica, Suzhou Suplead Life Sciences

Sep. 9, 2019

Asthma symptoms have distinct origins, common target

Sep. 9, 2019

Genentech describes lead small-molecule IRAK-4 inhibitors

Sep. 9, 2019

Rock-paper-synthetic biology

Sep. 9, 2019

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...